China Resources Medical Holdings Co (HKSE:01515) EBIT : HK$982 Mil (TTM As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is China Resources Medical Holdings Co EBIT?

China Resources Medical Holdings Co's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$718 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$982 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Resources Medical Holdings Co's annualized ROC % for the quarter that ended in Jun. 2024 was 8.23%. China Resources Medical Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 24.78%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Resources Medical Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 14.57%.

China Resources Medical Holdings Co EBIT Historical Data

The historical data trend for China Resources Medical Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Medical Holdings Co EBIT Chart

China Resources Medical Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT

Get a 7-Day Free Trial

515.91

351.07

534.73

664.78

975.79

China Resources Medical Holdings Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT	Get a 7-Day Free Trial															166.95	750.64	-85.85	718.24	263.48

Competitive Comparison of China Resources Medical Holdings Co's EBIT

For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Medical Holdings Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Resources Medical Holdings Co's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

China Resources Medical Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$982 Mil.

China Resources Medical Holdings Co (HKSE:01515) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Resources Medical Holdings Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	1223.272 * ( 1 - 18.44% )	/	( (12779.631	+	11469.926)	/ 2 )
=	997.7006432	/	12124.7785
=	8.23 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	14934.667	-	4100.097	-	( 1352.017	-	max(0, 5695.715	-	3750.654	+	1352.017	))
=	12779.631

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	14768.81	-	3931.018	-	( 1389.271	-	max(0, 4424.131	-	3791.997	+	1389.271	))
=	11469.926

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

China Resources Medical Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1436.472	/	( ( (5888.094 + max(-1676.893, 0))	+	(5703.37 + max(-1461.904, 0)) )	/	2 )
=	1436.472	/	( ( 5888.094	+	5703.37 )	/	2 )
=	1436.472	/	5795.732
=	24.78 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2167.028	+	330.404	+	74.428)	-	(4100.097	+	0	+	148.656)
=	-1676.893

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2138.77	+	295.179	+	57.887999999999)	-	(3931.018	+	0	+	22.723)
=	-1461.904

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Resources Medical Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	981.712	/	6737.447
	=	14.57 %

China Resources Medical Holdings Co EBIT Related Terms

Thank you for viewing the detailed overview of China Resources Medical Holdings Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Medical Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Resources Medical Holdings Co Ltd (HKSE:01515) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

1PH:Germany

Address

No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069

Website

http://www.crmedical.hk

China Resources Medical Holdings Co Ltd provides a full spectrum of general healthcare services, hospital management services, and also group purchasing organization business, and other derived businesses from hospitals in Mainland China. The group has two operating segments: Hospital Business, and Others Business. The Hospital Business segment includes outpatient business, inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services and other ancillary services provided to participating hospitals and IOT/OT hospitals.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Mitsubishi Ufj Financial Group, Inc.	2201 Interest of corporation controlled by you

China Resources Medical Holdings Co Headlines

No Headlines